A prospective study of lycopene and tomato product intake and risk of prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 1, 2006, Pages 92-98

  Kirsh, Victoria A ^a,b,f   Mayne, Susan T ^b   Peters, Ulrike ^a,g   Chatterjee, Nilanjan ^a   Leitzmann, Michael F ^a   Dixon, L Beth ^c   Urban, Donald A ^d   Crawford, E David ^e   Hayes, Richard B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d Kentucky   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f CANCER CARE ONTARIO   (Canada)

^g Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; LYCOPENE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CAROTENOID;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILY HISTORY; FAT INTAKE; FOLLOW UP; FOOD COMPOSITION; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; TOMATO; AGED; CLINICAL TRIAL; DIET; GENETIC PREDISPOSITION; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATE TUMOR; RISK ASSESSMENT; UNITED STATES;

AGED; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CAROTENOIDS; DIET; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYCOPERSICON ESCULENTUM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK ASSESSMENT; UNITED STATES;

EID: 33645453765     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0563     Document Type: Article

References (55)

1. Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am 2003;30:209-17.
2. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003; 349:366-81.
3. Mills PK, Beeson WL, Phillips RL, et al. Cohort study of diet, lifestyle, and prostate-cancer in Adventist men. Cancer 1989;64:598-604.
4. Giovannucci E, Rimm EB, Liu Y, et al. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002;94:391-8.
5. Schuman LM, Mandel JS, Radke A, et al. Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, Minnesota case control study, 1976-1979. In: Trends in cancer incidence: causes and practical implications. Washington: Hemisphere Publishing Corp.; 1982. p. 345-54.
6. Jain MG, Hislop GT, Howe GR, et al. Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr Cancer 1999;34:173-84.
7. Tzonou A, Signorello LB, Lagiou P, et al. Diet and cancer of the prostate: a case-control study in Greece. Int J Cancer 1999;80:704-8.
8. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000;92:61-8.
9. Norrish AE, Jackson RT, Sharpe SJ, et al. Prostate cancer and dietary carotenoids. Am J Epidemiol 2000;151:119-23.
10. Hsing AW, Comstock GW, Abbey H, et al. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-6.
11. Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999;59:1225-30.
12. Lu QY, Hung JC, Heber D, et al. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev 2001;10:749-56.
13. Vogt TM, Mayne ST, Graubard BI, et al. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol 2002;155:1023-32.
14. Schuurman AG, Goldbohm RA, Dorant E, et al. Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol Biomarkers Prev 1998;7:673-80.
15. Le Marchand L, Hankin JH, Kolonel LN, et al. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol 1991;133:215-9.
16. Key TJ, Silcocks PB, Davey GK, et al. A case-control study of diet and prostate cancer. Br J Cancer 1997;76:678-87.
17. Deneo-Pellegrini H, De Stefani E, Ronco A, et al. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer 1999;80:591-7.
18. Hayes RB, Ziegler RG, Gridley G, et al. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:25-34.
19. Villeneuve PJ, Johnson KC, Kreiger N, et al. Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 1999;10:355-67.
20. Kolonel LN, Hankin JH, Whittemore AS, et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000;9:795-804.
21. Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr 1991;53:260-4S.
22. Nomura AM, Stemmermann GN, Lee J, et al. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-91.
23. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2004;13:340-5.
24. US Department of Agriculture. US Food supply database. Beltsville (MD): Center for nutrition and policy promotion, 2003. Available from: http:// www.ars.usda.gov/ba/bhnrc/ndl.
25. Chug-Ahuja JK, Holden JM, Forman MR, et al. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J Am Diet Assoc 1993;93:318-23.
26. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998;56:35-51.
27. Agarwal A, Shen H, Agarwal S, et al. Lycopene content of tomato products: its stability, bioavailability and in vivo antioxidant properties. J Med Food 2001;4:9-15.
28. Heber D, Lu QY. Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 2002;227:920-3.
29. Cooper DA, Webb DR, Peters JC. Evaluation of the potential for olestra to affect the availability of dietary phytochemicals. J Nutr 1997;127:1699-709S.
30. Gartner C, Stahl W, Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 1997;66:116-22.
31. Giovannucci E. Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. J Nutr 2005;135:2030-1S.
32. Hayes RB, Sigurdson A, Moore L, et al. Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res 2005;592(1-2):147-54.
33. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21:273-309S.
34. Fleming ID, Cooper JS, Henson DE, et al., editors. AJCC cancer staging manual. 5th ed. Philadelphia (PA): Lippincott-Raven; 1997.
35. Potischman N, Carroll RJ, Iturria SJ, et al. Comparison of the 60- and 100-item NCI-block questionnaires with validation data. Nutr Cancer 1999;34:70-5.
36. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122: 51-65.
37. Tippett KSCY. Design and operation: the continuing survey of food intakes by individuals and the diet and health knowledge survey, 1994-96. In: Continuing survey of food intakes by individuals 1994-96. Nationwide Food Surveys Rep No 96-1. US Department of Agriculture, Agricultural Research Service 1998.
38. Subar AF, Midthune D, Kulldorff M, et al. Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 2000;152:279-86.
39. Nutrition Coordinating Center, Nutrition Data System for Research (NDS-R). Version 4.06/34. Minnesota: University of Minnesota; 2003.
40. Dixon LB, Zimmerman TP, Kahle LL, et al. Adding carotenoids to the NCI Diet History Questionnaire Database. Journal of Food Composition and Analysis 2003;16:269-80.
41. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
42. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
43. Wu K, Erdman JW, Jr., Schwartz SJ, et al. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2004;13:260-9.
44. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76.
45. Stahl W, Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 1992;122:2161-6.
46. Boileau AC, Merchen NR, Wasson K, et al. cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J Nutr 1999;129:1176-81.
47. Shi J, Le Maguer M. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Food Sci Nutr 2000;40:1-42.
48. Clinton SK, Emenhiser C, Schwartz SJ, et al. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996;5:823-33.
49. Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001;93:1872-9.
50. Paetau I, Khachik F, Brown ED, et al. Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am J Clin Nutr 1998;68:1187-95.
51. Kotake-Nara E, Kushiro M, Zhang H, et al. Carotenoids affect proliferation of human prostate cancer cells. J Nutr 2001;131:3303-6.
52. Williams AW, Boileau TW, Zhou JR, et al. Beta-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol. J Nutr 2000;130:728-32.
53. Boileau TW, Liao Z, Kim S, et al. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 2003;95:1578-86.
54. Li H, Kantoff PW, Giovannucci E, et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005;65:2498-504.
55. Weiss NS. Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it. Am J Epidemiol 2003;157:957-61.